Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2014. Start Trial.
Date Value
October 23, 2026 10.01M
October 22, 2026 10.41M
October 21, 2026 11.07M
October 20, 2026 10.94M
October 19, 2026 10.80M
October 16, 2026 11.07M
October 15, 2026 11.27M
October 14, 2026 11.60M
October 13, 2026 13.25M
October 12, 2026 13.65M
October 09, 2026 13.51M
October 08, 2026 13.51M
October 07, 2026 13.91M
October 06, 2026 13.98M
October 05, 2026 13.98M
October 02, 2026 14.18M
October 01, 2026 13.65M
September 30, 2026 14.31M
September 29, 2026 12.99M
September 28, 2026 12.72M
September 25, 2026 11.99M
September 24, 2026 11.93M
September 23, 2026 11.33M
September 22, 2026 11.66M
September 21, 2026 11.20M
Date Value
September 18, 2026 11.00M
September 17, 2026 10.67M
September 16, 2026 10.67M
September 15, 2026 10.80M
September 14, 2026 11.40M
September 11, 2026 11.46M
September 10, 2026 11.86M
September 09, 2026 11.60M
September 08, 2026 11.07M
September 04, 2026 10.34M
September 03, 2026 9.745M
September 02, 2026 9.613M
September 01, 2026 9.414M
August 31, 2026 9.679M
August 28, 2026 9.481M
August 27, 2026 9.679M
August 26, 2026 10.01M
August 25, 2026 9.877M
August 24, 2026 9.679M
August 21, 2026 9.811M
August 20, 2026 9.547M
August 19, 2026 10.08M
August 18, 2026 10.27M
August 17, 2026 10.41M
August 14, 2026 10.41M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
ClearPoint Neuro, Inc. 313.38M
Abbott Laboratories 207.10B
AngioDynamics, Inc. 501.34M
Alphatec Holdings, Inc. 2.205B
AtriCure, Inc. 2.906B